+44 1223 790975
Leonard Pinchuk, J. F. Batlle, I Riss, Y. P. Kato, Y. Kwon, B. A. Weber, J. B. Martin and J-M. Parel
Scientific Tracks Abstracts: J Clin Exp Ophthalmol
Miguel Rechichi has completed his training in ophthalmology at 28 and his Ph.D. at 32 from Magna Graecia University and Diploma of Specialist Superior in Ophthalmology from University of Lugano (Switzerland). He?s actually a researcher for Magna Graecia University and Director of corneal and refractive Surgery service of S. Lucia Eye Clinic, Cosenza, Italy. He was a pioneer of crosslinking clinical application and actually is involved in developing new accelerated cxl protocols for which he?s invited as opinion leader to several meetings. He has published several papers in reputed journals and has been serving as an editorial board member of repute.
Leonard Pinchuk is the inventor of the modern-day angioplasty balloon, various stents and stent-grafts, the polycarbonate urethanes and SIBS for implant applications, the TAXUS drug-eluting coronary stent, the InnFocusMicroShunt? for glaucoma, the Surefire Catheter for liver tumors and xPIB for IOLs. He began his career at Cordis Corporation in 1983, left in 1987 to co-found Corvita Corporation, which went public in 1994, was purchased by Pfizer (1996) and then Boston Scientific (1998). Dr. Pinchuk founded Innovia LLC in 2002, which spun off InnFocus in 2004. Dr. Pinchuk received a B.Sc. in chemistry from McGill University in 1976, a Ph.D. interdisciplinary in Engineering and Chemistry from the University of Miami in 1984 and an honorary Doctor of Science degree from McGill University in 2005. He was inducted into the National Academy of Engineering in 2012.